SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Johnell Olof) "

Sökning: WFRF:(Johnell Olof)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Eriksson, Anna-Lena, 1971, et al. (författare)
  • SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density.
  • 2006
  • Ingår i: The Journal of clinical endocrinology and metabolism. - : Oxford University Press. - 0021-972X .- 1945-7197. ; 91:12, s. 5029-37
  • Tidskriftsartikel (refereegranskat)abstract
    • CONTEXT: SHBG regulates free sex steroid levels, which in turn regulate skeletal homeostasis. Twin studies have demonstrated that genetic factors largely account for interindividual variation in SHBG levels. Glucuronidated androgen metabolites have been proposed as markers of androgenic activity. OBJECTIVE: Our objective was to investigate whether polymorphisms in the SHBG gene promoter [(TAAAA)(n) microsatellite and rs1799941 single-nucleotide polymorphism] are associated with serum levels of SHBG, sex steroids, or bone mineral density (BMD) in men. DESIGN AND STUDY SUBJECTS: We conducted a population-based study of two cohorts of Swedish men: elderly men (MrOS Sweden; n congruent with 3000; average age, 75.4 yr) and young adult men (GOOD study; n = 1068; average age, 18.9 yr). MAIN OUTCOME MEASURES: We measured serum levels of SHBG, testosterone, estradiol, dihydrotestosterone, 5alpha-androstane-3alpha,17beta-diol glucuronides, androsterone glucuronide, and BMD determined by dual-energy x-ray absorptiometry. RESULTS: In both cohorts, (TAAAA)(n) and rs1799941 genotypes were associated with serum levels of SHBG (P < 0.001), dihydrotestosterone (P < 0.05), and 5alpha-androstane-3alpha,17beta-diol glucuronides (P < 0.05). In the elderly men, they were also associated with testosterone and BMD at all hip bone sites. The genotype associated with high levels of SHBG was also associated with high BMD. Interestingly, male mice overexpressing human SHBG had increased cortical bone mineral content in the femur, suggesting that elevated SHBG levels may cause increased bone mass. CONCLUSIONS: Our findings demonstrate that polymorphisms in the SHBG promoter predict serum levels of SHBG, androgens, and glucuronidated androgen metabolites, and hip BMD in men.
  •  
2.
  •  
3.
  • Bauer, M, et al. (författare)
  • Ankle fractures
  • 1987
  • Ingår i: Foot and Ankle. - : SAGE Publications. - 0198-0211. ; 8:1, s. 23-25
  • Tidskriftsartikel (refereegranskat)abstract
    • The results of three separate studies on ankle fractures are presented. Clinical information is provided concerning the epidemiology and a comparison of closed versus open treatment, and a discussion is presented concerning what results can be expected 30 years after closed treatment for an ankle fracture.
  •  
4.
  • Bauer, M, et al. (författare)
  • Supination-eversion fractures of the ankle joint: changes in incidence over 30 years
  • 1987
  • Ingår i: Foot and Ankle. - : SAGE Publications. - 0198-0211. ; 8:1, s. 26-28
  • Tidskriftsartikel (refereegranskat)abstract
    • The sex- and age-specific incidence has been calculated for ankle fractures from the first part of the 1950s and compared with the 1980s, a 30-year interval. The fractures were also classified according to Lauge-Hansen. Altogether 1784 fractures were found. During that time interval ankle fractures had become more common, particularly those with extensive skeletal involvement, such as the stage IV supination-eversion fractures, which today have an incidence pattern more typical of a fragility fracture in elderly women.
  •  
5.
  • Bengner, Urban, et al. (författare)
  • Changes in incidence and prevalence of vertebral fractures during 30 years
  • 1988
  • Ingår i: Calcified Tissue International. - : Springer. - 1432-0827. ; 42:5, s. 293-296
  • Tidskriftsartikel (refereegranskat)abstract
    • The age and sex-specific incidence and prevalence of vertebral compression fractures were compared between the 1950s and 1980s in an urban population. In women over 80 years of age the incidence of symptomatic vertebral fractures has increased approximately four times; in elderly men even more. Mainly, low-energy trauma has caused these fractures. Thus, one clinical manifestation of osteoporosis--vertebral fracture--has increased in number, incidence, and prevalence over the last 30 years.
  •  
6.
  • Bengner, Urban, et al. (författare)
  • Changes in the incidence of fracture of the upper end of the humerus during a 30-year period. A study of 2125 fractures
  • 1988
  • Ingår i: Clinical Orthopaedics and Related Research. - : Lippincott Williams & Wilkins. - 0009-921X. ; 231, s. 179-182
  • Tidskriftsartikel (refereegranskat)abstract
    • The incidence of fracture of the upper end of the humerus by age group and sex was studied for a 32-year period from 1950 to 1982. The following numbers of humeral fractures occurred: 1950-1954, 411 fractures; 1961-1964, 552 fractures; 1971-1973, 639 fractures; and 1981-1982, 523 fractures. There was a progressive increase in the age-related incidence in older persons, especially in women. There was a higher incidence of fractures classified as severe in the 1980s compared with the 1950s.
  •  
7.
  • Bengnér, Urban, et al. (författare)
  • Epidemiology of ankle fracture 1950 and 1980. Increasing incidence in elderly women
  • 1986
  • Ingår i: Acta Orthopaedica Scandinavica. - : Taylor & Francis. - 0001-6470. ; 57:1, s. 35-37
  • Tidskriftsartikel (refereegranskat)abstract
    • During 1980-82, 739 ankle fractures occurred in Malmo. These were compared with 383 ankle fractures occurring in 1950-52. In men there was an increase in the age-specific incidence up to the age of 60, especially in fractures of the lateral malleolus. In women there was an increase in the age-specific incidence above the age of 50, both in lateral malleolar fractures and, even more pronounced, in bi- and tri- malleolar fractures.
  •  
8.
  • Bengnér, Urban, et al. (författare)
  • Increasing incidence of tibia condyle and patella fractures
  • 1986
  • Ingår i: Acta Orthopaedica Scandinavica. - : Taylor & Francis. - 0001-6470. ; 57:4, s. 334-336
  • Tidskriftsartikel (refereegranskat)abstract
    • The age and sex specific incidence of tibial condyle fractures and patellar fractures were compared between 1950-55 and 1980-83 in the urban population of Malmo. In elderly women there was an increased incidence over these 30 years for both fracture types.
  •  
9.
  • Bergenudd, H, et al. (författare)
  • The articular cartilage after osteotomy for medial gonarthrosis. Biopsies after 2 years in 19 cases
  • 1992
  • Ingår i: Acta Orthopaedica Scandinavica. - : Taylor & Francis. - 0001-6470. ; 63:4, s. 413-416
  • Tidskriftsartikel (refereegranskat)abstract
    • In 19 consecutive patients with medial gonarthrosis, an arthroscopic examination with a biopsy of the load-bearing cartilage in the medial femoral condyle was undertaken at the same time as a proximal tibial osteotomy. A follow-up arthroscopic biopsy was performed on an average of 2 years after the osteotomy. In 9 knees there was an improvement in the cartilage quality, 8 knees were unchanged, whereas 2 knees had deteriorated. Radiographically, 6 knees had improved, 11 were unchanged and 2 had deteriorated. We found no correlation between cartilage improvement and the clinical and radiographic outcome. Our results confirm that an osteotomy has a beneficial effect on the load-bearing cartilage in the medial femoral condyle.
  •  
10.
  • Borgstrom, F, et al. (författare)
  • The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
  • 2006
  • Ingår i: Osteoporosis International. - : Springer. - 1433-2965. ; 17:7, s. 996-1007
  • Tidskriftsartikel (refereegranskat)abstract
    • Introduction: Risedronate, a bisphosphonate for treatment and prevention of osteoporosis, has been shown in several clinical trials to reduce the risk of fractures in postmenopausal women with osteoporosis. The cost-effectiveness of risedronate treatment has previously been evaluated within different country settings using different model and analysis approaches. The objective of this study was to assess the cost-effectiveness of risedronate in postmenopausal women in four European countries-Sweden, Finland, Spain, and Belgium-by making use of the same modelling framework and analysis setup. Methods: A previously developed Markov cohort model for the evaluation of osteoporosis treatments was used to estimate the cost-effectiveness of risedronate treatment. For each country, the model was populated with local mortality, fracture incidence, and cost data. Hip fractures, clinical vertebral fractures, and wrist fractures were included in the model. Results: The incremental cost per quality-adjusted life years (QALY) gained from a 5-year intervention with risedronate compared to "no intervention" in 70-year-old women at the threshold of osteoporosis [T-score = -2.5 based on National Health and Nutrition Examination Survey (NHANES) III data] and previous vertebral fracture was estimated to be E860, E19,532, E11,782, and E32,515 in Sweden, Finland, Belgium, and Spain, respectively. Among 70-year-old women at the threshold of osteoporosis without previous fracture the estimated cost per QALY gained ranged from E21,148 (Sweden) to E80,100 (Spain). The differences in cost-effectiveness between countries are mainly explained by different costs (fracture and treatment costs), fracture risks, and discount rates. Based on cost per QALY gained threshold values found in the literature, the study results indicated risedronate to be cost effective in the treatment of elderly women with established osteoporosis in all the included countries. Conclusions: At a hypothetical threshold value of E40,000 per QALY gained, the results in this study indicate that risedronate is a cost-effective treatment in elderly women at the threshold of osteoporosis (i.e., a T-score of -2.5) with prevalent vertebral fractures in Sweden, Finland, Belgium, and Spain.
  •  
Skapa referenser, mejla, bekava och länka
Typ av publikation
tidskriftsartikel (156)
forskningsöversikt (4)
bokkapitel (2)
bok (1)
rapport (1)
annan publikation (1)
visa fler...
konferensbidrag (1)
doktorsavhandling (1)
visa färre...
Typ av innehåll
refereegranskat (154)
övrigt vetenskapligt (12)
populärvet., debatt m.m. (1)
Författare/redaktör
Johnell, Olof (164)
Kanis, JA (44)
Oden, A (35)
Redlund-Johnell, Ing ... (35)
De Laet, C (29)
Jonsson, B (28)
visa fler...
Johnell, O. (27)
Kanis, J A (22)
Odén, Anders, 1942 (17)
Sernbo, Ingemar (16)
Johansson, Helena, 1 ... (16)
Obrant, Karl (16)
Johansson, H (15)
Reeve, J. (15)
Borgstrom, F (14)
Mellström, Dan, 1945 (12)
Mellstrom, D. (12)
Karlsson, Magnus (10)
Cooper, C. (10)
Kanis, John A (10)
Tenenhouse, A. (10)
Lidgren, Lars (9)
Silman, A (9)
Melton, LJ (9)
Delmas, P. (8)
Sernbo, I (8)
De Laet, Chris (8)
Boonen, S (7)
Eisman, JA (7)
Karlsson, M. K. (7)
Bengner, Urban (7)
Zethraeus, N (7)
McCloskey, EV (7)
Fujiwara, S. (7)
Rizzoli, R. (6)
Seeman, E (6)
Hasserius, Ralph (6)
Ljunggren, Östen (6)
Jönsson, Bengt (6)
Åkesson, Kristina (6)
Eisman, J.A. (6)
Mallmin, Hans (5)
Rogmark, Cecilia (5)
Holmberg, Anna H (5)
Pols, HAP (5)
Ornstein, Ewald (5)
Kroger, H (5)
McCloskey, E (5)
Silman, AJ (5)
Melton, L J (5)
visa färre...
Lärosäte
Lunds universitet (158)
Göteborgs universitet (21)
Karolinska Institutet (13)
Uppsala universitet (8)
Umeå universitet (2)
Språk
Engelska (160)
Svenska (6)
Odefinierat språk (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (159)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy